Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

DEXCOM, INC. (DXCM)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Discover our TOP LISTS, the world's most profitable stocks to hold Get it NOW!
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/19/2017 06/20/2017 06/21/2017 06/22/2017 06/23/2017 Date
77.96(c) 77.84(c) 78.33(c) 78.68(c) 77.33 Last
1 382 482 1 357 524 991 293 770 738 891 910 Volume
+2.23% -0.15% +0.63% +0.45% -1.72% Change
More quotes
Financials ($)
Sales 2017 726 M
EBIT 2017 -57,4 M
Net income 2017 -59,1 M
Finance 2017 131 M
Yield 2017 -
Sales 2018 954 M
EBIT 2018 8,04 M
Net income 2018 4,98 M
Finance 2018 191 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 1 082,26
EV / Sales2017 9,18x
EV / Sales2018 6,92x
Capitalization 6 794 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes.Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps.The company was... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
06/22 DEXCOM : New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Dail..
06/20 DEXCOM SCHEDULES SECOND QUARTER 2017 : 30 p.m. Eastern Time
06/15 DEXCOM : to Add Ambulatory Glucose Profile AGP to Dexcom CLARITY®
06/12 DEXCOM INC : Other Events (form 8-K)
06/09 DEXCOM : New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Dail..
06/09 DEXCOM : New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Dail..
06/08 DEXCOM : to Add Ambulatory Glucose Profile (AGP) to Dexcom CLARITY®
06/07 DEXCOM : Announces FDA Approval of G5 Mobile App for Android Devices
06/06 DEXCOM INC : Change in Directors or Principal Officers, Amendments to Articles o..
06/02 DEXCOM : Sources Sought Notice - 65-- Dexcom G4 Platinum System SOURCES SOUGHT N..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/16 Earnings drag on European shares, though Vodafone lifts telcos
05/09 French outbound M&A driven to decade high by big deals
05/06DJProfits Jump, Spending Lags -- WSJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
06/21Dexcom CEO talks ‘game changer' diabetes management coming to Apple Watch  
06/21Dexcom CEO talks 'game changer' diabetes management coming to Apple Watch  
06/21DexCom, Inc. $DXCM Raised to Buy at BidaskClub  
06/211,934 Shares in DexCom, Inc. $DXCM Acquired by Edmond DE Rothschild Holding S.. 
06/21Dexcom CEO talks ‘game changer’ diabetes management coming to Apple Watch
39
More tweets
Qtime:42
News from SeekingAlpha
06/09 WEAR ETF (WEAR) May Summary
06/06 VAREX : An Overlooked Spin-Off With 25% Upside
06/05 DexCom shares up over 4% on Apple glucose data inclusion
06/01 Lean Long-Term Growth Portfolio - May 2017 Update
05/30 Dexcom's Implantable Blood Sugar Monitor Sales Rise
Advertisement
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 90,1 $
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terrance H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Kevin Sun Chief Financial Officer & Vice President
Jacob Leach Senior Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.31.79%6 794
MEDTRONIC PLC24.65%121 954
BAXTER INTERNATIONAL36.85%32 990
ZIMMER BIOMET HOLDINGS..25.38%26 091
C R BARD INC40.65%22 882
HOYA CORPORATION15.48%19 735
More Results